Publication | Closed Access
Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts
48
Citations
17
References
2000
Year
OncologyHuman Tumor XenograftsMedicinePathologyTumor TargetingAnti-cancer AgentCancer TreatmentPharmacologyAnticancer EfficacyCancer ResearchTumor BiologyCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1